Action PRTC PURETECH HEALTH PLC
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués PureTech Health plc

Actions

PRTC

GB00BY2Z0H74

Marché Fermé - London S.E.
Autres places de cotation
 17:35:26 28/06/2024 		Varia. 5j. Varia. 1 janv.
183 GBX -2,56% Graphique intraday de PureTech Health plc -12,44% -5,77%
25/06 PureTech Health rachète 100 millions de dollars d'actions MT
24/06 RÉSULTATS ET TRANSACTIONS : PureTech scelle son offre publique d'achat ; l'offre de HL est remise en question AN

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
PureTech Health: Results of the Tender Offer
BU
PureTech Announces Change of Board Role
BU
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team
BU
PureTech Health: Results of Annual General Meeting
BU
PureTech Health: Result of General Meeting
BU
PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company
BU
PureTech to Present at the Jefferies Global Healthcare Conference
BU
PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection
BU
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
BU
PureTech Health : Shareholder Circular regarding Proposed Tender Offer
PU
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry Annual Meeting
AQ
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
BU
PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
BU
PureTech Health : Proxy Form for 2024 AGM
PU
PureTech Health : Notice of Meeting for 2024 AGM
PU
PureTech Announces Annual Results for Year Ended December 31, 2023
BU
PureTech Health plc - Notice of Results
AQ
PureTech Health: Notice of Results
BU
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 in Idiopathic Pulmonary Fibrosis
AQ
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
BU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PRTC
  4. Actualités PureTech Health plc
  5. Communiqués